New gene test may sharpen diagnosis of tricky breast lumps
NCT ID NCT07416500
First seen Feb 28, 2026 · Last updated May 19, 2026 · Updated 12 times
Summary
This study looked at whether testing for changes in three genes (BRCA1, RASSF1A, and PTEN) in breast tissue can help doctors better diagnose breast lesions that are hard to classify. Researchers took extra tissue samples from 301 women with suspicious breast lumps and analyzed the genes' methylation patterns. The goal was to see if these genetic markers could improve the accuracy of distinguishing benign from malignant lesions, potentially reducing unnecessary surgeries or missed cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.